Molecular Partners Ag (MOLN) EBIT Margin (QoQ) (2020 - 2024)
Powered by 
Analysis
Molecular Partners Ag (MOLN) EBIT Margin (QoQ) (2020 - 2024) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Molecular Partners Ag | 156.54 Mn | 156.54 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 336,844.00 |
| Sep 30, 2024 | -111,225.00 |
| Jun 30, 2024 | -45,086.00 |
| Mar 31, 2024 | 28,919.00 |
| Dec 31, 2023 | -33,751.00 |
| Sep 30, 2023 | 329,637.00 |
| Jun 30, 2023 | -333,254.00 |
| Mar 31, 2023 | -55,618.00 |
| Dec 31, 2022 | 68,298.00 |
| Sep 30, 2022 | -56,797.00 |
| Jun 30, 2022 | -14,181.00 |
| Mar 31, 2022 | 73,851.00 |
| Dec 31, 2021 | -28,687.00 |
| Sep 30, 2021 | 42,412.00 |
| Jun 30, 2021 | 110,916.00 |
| Mar 31, 2021 | -127,148.00 |
| Dec 31, 2020 | -598,592.00 |